Gut, 19 March 2012, Vol.61(3), p.427
Hepatocellular carcinoma (HCC) is a heterogeneous disease with poor prognosis and limited methods for predicting patient survival. The nature of the immune cells that infiltrate tumours is known to impact clinical outcome. However, the molecular events that regulate this infiltration require further understanding. Here the ability of immune genes expressed in the tumour microenvironment to predict disease progression was investigated.
Hepatocellular Carcinoma ; Immune-Gene Signature ; Tumour Microenvironment ; Chemokines ; Lymphocytes Tumour Infiltration ; Immunology in Hepatology ; Tumour Markers ; Liver Immunology ; Immunohistochemistry ; Acute Hepatitis ; Cancer ; Oncogenes ; Gastric Cancer ; Liver Metastases ; Pancreatic Pathology ; Pancreatic Tumours ; Molecular Pathology ; Gastrointestinal Lymphoma ; Liver Biopsy ; Surgical Complications ; Surgical Oncology ; Surgical Resection ; Immune Response ; Unlocked
View this record in BMJ Journals